As far as I know, there is no separate "blood loss policy", as opposed to other types of Adverse Event. If the incident would be regarded by a qualified medical professional (doctor, nurse, biomedical engineer or risk manager) as an Adverse Event, those rules apply.
The general expectation is that if you can't show via objective evidence that the incident didn't involve your product, you should report it.